(Total Views: 329)
Posted On: 10/02/2025 4:44:35 AM
Post# of 157634
Quote:
The second is that a plethora of fully informed patient/doctor enrollment candidates would therefore pass on LL at 350 mg.
The doctors would be briefed on the DSMB potentially switching over to 700mg for all patients. With other avenues of treatment exhausted and unlike other treatments, minor side effects, doctors should be happy to use leronlimab.
(15)
(0)
